De la Peña-Arteaga, V, Chavarría-Elizondo, P, Juaneda-Seguí, A, Martínez-Zalacaín, I, Morgado, P, Menchón, JM, Picó-Pérez, M, Fullana, MA, Soriano-Mas, C. Trait anxiety is associated with attentional brain networks. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2024; 83DOI:10.1016/j.euroneuro.2024.02.013. PMID:38492550. IF:6.700(Q1/1D).

Almodóvar-Payá, C, Guardiola-Ripoll, M, Giralt-López, M, Oscoz-Irurozqui, M, Canales-Rodríguez, EJ, Madre, M, Soler-Vidal, J, Ramiro, N, Callado, LF, Arias, B, Gallego, C, Pomarol-Clotet, E, Fatjó-Vilas, M. NRN1 epistasis with BDNF and CACNA1C: mediation effects on symptom severity through neuroanatomical changes in schizophrenia. Brain Structure & Function. 2024; 229(5)DOI:10.1007/s00429-024-02793-5. PMID:38720004. IF:2.900(Q1/1D).

Gracia-Liso, R, Portella, MJ, Pujals-Altes, E, Punti-Vidal, J, Llorens, M, Pamias, M, Jimenez, MF, Aguirrezabala, IM, Palao, DJ. Comparing frequencies of adolescent suicide attempters pre- and during COVID-19 pandemic school terms. BMC Psychiatry. 2024; 24(1)DOI:10.1186/s12888-024-05823-y. PMID:38760731. IF:3.600(Q1/3D).

Palazón-Llecha, A, Caparrós, B, Trujols, J, Duran-Sindreu, S, Batlle, F, Madre, M, Mallorquí-Bagué, N. Predictors of cocaine use disorder treatment outcomes: a systematic review. Systematic Reviews. 2024; 13(1)DOI:10.1186/s13643-024-02550-z. PMID:38720357. IF:3.900(Q1/2D).

de Girolamo, G, Andreassen, OA, Bauer, M, Brambilla, P, Calza, S, Citera, N, Corcoy, R, Fagiolini, A, Garcia-Argibay, M, Godin, O, Klingler, F, Kobayashi, NF, Larsson, H, Leboyer, M, Matura, S, Martinelli, A, de la Pena-arteaga, V, Poli, R, Reif, A, Ritter, P, Rodevand, LN, Magno, M, Caselani, E, Bayas, M, Bellivier, F, Alvarez, NC, Carmellini, P, Cevoli, F, Clemens, J, Courtet, P, Consoli, L, Delvecchio, G, Dobrosavljevic, M, Etain, B, Friedrichsen, H, Kelemen, A, Koukouna, D, Mato, E, Mauricio, D, Miranda-Olivos, R, Moebius, L, Moltrasio, C, Mohn-Haugen, C, Nuss, I, Olie, E, Pelletier, A, Rahman, Z, Rampi, D, Repple, J, Resmini, E, Schneider, J, Toffol, E. Medical comorbidities in bipolar disorder (BIPCOM): clinical validation of risk factors and biomarkers to improve prevention and treatment. Study protocol. International Journal of Bipolar Disorders. 2024; 12(1)DOI:10.1186/s40345-024-00337-8. PMID:38703295. IF:3.500(Q1/3D).

Garcia-Marti G., Escarti M.J., Nacher J., Perez-Rando M., Mane A., Usall J., Berrocoso E., Pomarol-Clotet E., Lopez-Ilundain J.M., Cuesta M.J., Rodriguez-Jimenez R., Gonzalez-Pinto A., Mar L., Ibañez A., Roldan A., Janssen J., Parellada M., Amoretti S., Bernardo M., Sanjuan J., Aguilar E.J.. Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinations. SCHIZOPHRENIA RESEARCH. 2024; 267DOI:10.1016/j.schres.2023.11.011. PMID:38044223. IF:3.500(Q1/3D).

Llorca-Bofí, V, Madero, S, Amoretti, S, Cuesta, MJ, Moreno, C, González-Pinto, A, Bergé, D, Rodriguez-Jimenez, R, Roldán, A, García-León, MA, Ibáñez, A, Usall, J, Contreras, F, Mezquida, G, García-Rizo, C, Berrocoso, E, Bernardo, M, Bioque, M. Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia. SCHIZOPHRENIA RESEARCH. 2024; 267DOI:10.1016/j.schres.2024.03.011. PMID:38513331. IF:3.500(Q1/3D).

de la Pena-arteaga, V, Cano, M, Porta-Casteras, D, Vicent-Gil, M, Miquel-Giner, N, Martinez-Zalacain, I, Mar-Barrutia, L, Lopez-Sola, M, Andrews-Hanna, JR, Soriano-Mas, C, Alonso, P, Serra-Blasco, M, Lopez-Sola, C, Cardoner, N. Mindfulness-based cognitive therapy neurobiology in treatment-resistant obsessive-compulsive disorder: A domain-related resting-state networks approach. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2024; 82DOI:10.1016/j.euroneuro.2024.02.011. PMID:38503084. IF:6.700(Q1/1D).